Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Sleep quality in patients with primary aldosteronism
Franziska M Hanusch1, Evelyn Fischer2, Katharina Lang3
1Clinical Endocrinology, Charit Campus Mitte, Charitί University Medicine Berlin, Germany.
Treatment for primary aldosteronism (PA) improves exhaustion, but sleep quality remains a concern, especially for women. Further research into sleep disturbances in PA patients is needed.
Area of Science:
- Endocrinology
- Sleep Medicine
- Cardiology
Background:
- Primary aldosteronism (PA) is frequently diagnosed in patients with sleep apnea (SA), and PA patients exhibit a high prevalence of SA.
- Current treatments for PA, including adrenalectomy (ADX) and mineralocorticoid receptor (MR) blockade, aim to reduce associated comorbidities.
- However, the impact of these treatments on sleep quality in PA patients remains uninvestigated.
Purpose of the Study:
- To investigate the effectiveness of primary aldosteronism treatments on sleep quality.
- To compare sleep quality between different PA treatment modalities.
- To identify potential differences in sleep quality based on patient demographics, such as sex.
Main Methods:
- A prospective multi-center study involving two cohorts of PA patients: newly diagnosed (n=15) and those treated long-term (n=81).
- Assessment included biochemical parameters, 24-hour blood pressure monitoring, and validated questionnaires: Giessen Complaint List (GBB-24), Epworth Sleepiness Scale (ESS), and Pittsburgh Sleep Quality Index (PSQI).
- Data were analyzed before and after treatment initiation, and at long-term follow-up, with comparisons based on treatment type and sex.
Main Results:
- Newly diagnosed PA patients showed a significant improvement in exhaustion tendency (GBB-24 Z-scores) after treatment initiation.
- In the long-term cohort, no significant differences in GBB-24, ESS, or PSQI scores were observed compared to baseline.
- Female patients reported significantly lower sleep quality (higher PSQI scores) than male patients, irrespective of the PA treatment received.
Conclusions:
- Initiation of PA treatment positively impacts exhaustion tendency in newly diagnosed patients.
- Long-term PA treatment did not show significant improvements in overall sleep quality or daytime sleepiness in the studied cohorts.
- Female PA patients experience more sleep disturbances than male PA patients, even after treatment, highlighting a potential sex-specific issue in sleep quality management for PA.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure VI: Adjunct Therapies

